首页> 外国专利> Dosage forms and compositions for Administration of varying dosages of oxycodone Osmotic

Dosage forms and compositions for Administration of varying dosages of oxycodone Osmotic

机译:施用不同剂量羟考酮渗透剂的剂型和组合物

摘要

Claim 1: a controlled release dosage form for oral administration once a day of oxycodone that includes: (a) a Center of Drug comprising: (i) an Osmotic agent; and (ii) a low dose of oxycodone.Or one or more pharmaceutically acceptable salts thereof; (b) a semipermeable Membrane that surrounds at least part of the centre of drugs; and (c) an outlet Orifice through the semipermeable Membrane that communicates with the center of the drug in order to allow the release of Ox Icodone environment; where the center of the Drug After the moisture in the atmosphere exhibits aViscosity of about 50 to 100 cps CPS.Claim 8: a controlled release dosage form for oral administration once a day of oxycodone that includes: (a) a Center of Drug comprising: (i) a high dose of oxycodone, or one or more pharmaceutically acceptable salts thereof; and (ii) does not contain And an Osmotic agent; (b) a semipermeable Membrane that surrounds at least part of the centre of Drugs,And (c) an outlet Orifice through the semipermeable Membrane that communicates with the center of the drug to allow the release of oxycodone to environment; where the center of the Drug After the moisture in the atmosphere exhibits a viscosity of about 50 cps to from sal Between 100 cps.Claim 12: a controlled release dosage form for oral administration once a day of oxycodone that includes: (a) a Center of Drug comprising: (i) an Osmotic agent; and (ii) a low dose of oxycodone.Or one or more pharmaceutically acceptable salts thereof; (b) a semipermeable Membrane that surrounds at least part of the centre of drugs; and (c) an outlet Orifice through the semipermeable Membrane that communicates with the center of the drug in order to allow the release of Ox Icodone environment; where the rate of release is approximately 20% to 100%.Claim 13: a controlled release dosage form for oral administration once a day of oxycodone that includes: (a) a Center of Drug comprising: (i) a high dose of oxycodone.Or one or more pharmaceutically acceptable salts thereof; and (ii) does not contain an Osmotic agent; (b) a semipermeable Membrane that surrounds at least part of the centre of drugs; and (c) an outlet Orifice through the semipermeable Membrane that communicates with the Centre for Drugs Allow the release of oxycodone to environment; where the rate of release is approx.And 20% to 100%.
机译:权利要求1:用于口服一次羟考酮的控释剂型,其包括:(a)药物中心,其包含:(i)渗透剂;和(ii)低剂量的羟考酮或其一种或多种药学上可接受的盐; (b)至少部分围绕药物中心的半透膜; (c)穿过半透膜的出口孔,该出口孔与药物中心连通,以便释放Ox Icodone环境;权利要求8:用于每天一次羟考酮口服给药的控释剂型,其在大气中的水分在大气中的水分之后表现出约50至100cps的CPS的粘度,其包括:(a)药物中心,其包括: (i)高剂量的羟考酮或其一种或多种药学上可接受的盐; (ii)不含和渗透剂; (b)至少部分围绕药物中心的半透膜,和(c)通过半透膜的出口孔,该出口孔与药物中心连通,使羟考酮释放到环境中;此处的药物中心在大气中的水分之后表现出的粘度约为50 cps至100 cps之间。权利要求12:每天一次羟考酮口服给药的控释剂型,包括:(a)中心药物,其包含:(i)渗透剂; (ii)低剂量的羟考酮或其一种或多种药学上可接受的盐; (b)至少部分围绕药物中心的半透膜; (c)穿过半透膜的出口孔,该出口孔与药物中心连通,以便释放Ox Icodone环境;权利要求13:用于羟考酮每天口服一次的控释剂型,其包括:(a)药物中心,其包含:(i)高剂量的羟考酮。或其一种或多种药学上可接受的盐; (ii)不含渗透剂; (b)至少部分围绕药物中心的半透膜; (c)通过半透膜的出口孔,该孔与药物中心连通,使羟考酮释放到环境中;释放率约为20%至100%

著录项

  • 公开/公告号AR040245A1

    专利类型

  • 公开/公告日2005-03-23

    原文格式PDF

  • 申请/专利权人 ALZA CORPORATION;

    申请/专利号AR2003P101964

  • 发明设计人

    申请日2003-06-02

  • 分类号A61K9/20;A61K9/24;A61K9/30;A61K31/485;A61K9/00;

  • 国家 AR

  • 入库时间 2022-08-21 22:18:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号